Status:

COMPLETED

Oxaliplatin in Unresectable Hepatocellular Carcinoma

Lead Sponsor:

Sanofi

Conditions:

Carcinoma, Hepatocellular

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

Primary: * To determine the Tumor Response Rate of patients with hepatocellular carcinoma treated with the combination chemotherapy of Eloxatin+5-Fluorouracil/Leucovorin Secondary: * Safety and tol...

Eligibility Criteria

Inclusion

  • Patients must have histologically confirmed hepatocellular carcinoma
  • Patients must have measurable disease by CT scan
  • Patients with unresectable, recurrent or metastatic disease may be chemonaive or may be previously treated by chemotherapy.
  • The period of washout of prior chemotherapy must be greater than 4 weeks from date of randomization. The prior chemotherapy should not include platinum compounds.
  • WHO performance status: 0 to 2
  • Patients must have adequate organ and marrow function as defined below:
  • Leukocytes : ≥ 3,000/μl
  • Absolute neutrophil count :≥ 1,500/μl
  • Platelets : ≥ 80,000/μl
  • Total bilirubin : \< 3.0g/dl
  • ASAT/ALAT : ≤ 3 times the upper normal limits of the institute
  • Creatinine : \< 120μmol/l
  • Patients with no evidence of clinically significant neuropathy.

Exclusion

  • Documented allergy to platinum compound or to others study's drugs
  • Pregnant or lactating women or women of childbearing potential (e.g. not using adequate contraception)
  • Hematological disorder or malignancies
  • Metastasis to central nervous system
  • Other serious illness or medical conditions:
  • Active infectious disease
  • Congestive heart failure, or angina pectoris. Previous history of myocardial infarction within 1 year from study entry; uncontrolled hypertension or arrhythmia.
  • Concurrent treatment with any other anticancer therapy
  • Concurrent treatment with other experimental drugs.
  • The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Key Trial Info

Start Date :

July 1 2004

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00280618

Start Date

July 1 2004

Last Update

September 15 2009

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.